145 related articles for article (PubMed ID: 3324168)
1. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
Oyekan AO; Botting JH
Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
[TBL] [Abstract][Full Text] [Related]
2. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
Miller OV; Aiken JW; Shebuski RJ; Gorman RR
Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
[TBL] [Abstract][Full Text] [Related]
3. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
4. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths RJ; Moore PK
Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
Schwertschlag U; Stahl T; Hackenthal E
Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
[TBL] [Abstract][Full Text] [Related]
6. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
[TBL] [Abstract][Full Text] [Related]
7. A comparison of some pharmacological actions of prostaglandin E1, 6-oxo-PGE1 and PGI2.
Adaikan PG; Tai NY; Lau LC; Karim SM; Kottegoda SR
Prostaglandins; 1984 Apr; 27(4):505-16. PubMed ID: 6203140
[TBL] [Abstract][Full Text] [Related]
8. Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
Fitscha P; Kaliman J; Sinzinger H
Am J Hematol; 1985 May; 19(1):13-9. PubMed ID: 3885723
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
Weithmann KU; Just M; Schlotte V; Seiffge D
Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
[TBL] [Abstract][Full Text] [Related]
10. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
Wilsoncroft PS; Lofts FJ; Griffiths RJ; Moore PK
J Pharm Pharmacol; 1985 Feb; 37(2):139-41. PubMed ID: 2858551
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
McGiff JC; Spokas EG; Wong PY
Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
[TBL] [Abstract][Full Text] [Related]
12. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
13. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
Zilla P; Groscurth P; Varga G; Fischlein T; Fasol R
Exp Hematol; 1987 Aug; 15(7):741-9. PubMed ID: 3301381
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Mardla V; Kobzar G; Samel N
Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
[TBL] [Abstract][Full Text] [Related]
15. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
Sim AK; McCraw AP; Cleland ME; Nishio S; Umetsu T
Arzneimittelforschung; 1985; 35(12):1816-8. PubMed ID: 3913423
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
Khanna V; Armstrong PC; Warner TD; Curzen N
Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
[TBL] [Abstract][Full Text] [Related]
17. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
Katzenschlager R; Weiss K; Rogatti W; Peskar BA; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 1992 Mar; 45(3):207-10. PubMed ID: 1589447
[TBL] [Abstract][Full Text] [Related]
18. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
Kikura M; Kazama T; Ikeda T; Sato S
Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
[TBL] [Abstract][Full Text] [Related]
19. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
Eggerman TL; Hartzell CJ; Selfe S; Andersen NH
Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin releasing polymers - stability and efficacy.
McRea JC; Ebert CD; Kim SW
Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
